Jill Anzarut - a thorn to government, a champion to breast-cancer activists - is to start Herceptin on Friday for a half-centimetre tumour that was once deemed too small to treat.

Ontario is moving to join other provinces in funding the cancer drug Herceptin for small tumours following a public outcry sparked by a breast cancer patient.